{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T02:52:08Z","timestamp":1794711128618,"version":"4.9.1"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","license":[{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4,14]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Low molecular weight heparins are widely used in various thrombotic diseases and exert a preventive effect on thrombosis in high-risk patients. Umbilical artery thrombosis (UAT) is a rare occurrence that is difficult to detect during routine prenatal visits but can lead to adverse perinatal outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>The aim of this study was to elucidate the therapeutic effect of low molecular weight heparins on UAT and to provide a new treatment option for the timing of delivery timing.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses and interventions:<\/jats:title>\n            <jats:p>A retrospective study was conducted on cases involving thrombosis of the umbilical cord enrolled from July 2017 to July 2022. Data were acquired and analyzed from medical records and the final diagnosis was confirmed by histopathology. All included patients received LWMHs therapy after initial diagnosis of UAT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The mean age of the 10 pregnant women recruited into this study was 27.9\u2009\u00b1\u20094.0 year-of-age; 1 (10%) was elderly. The gestational age at diagnosis was 29.9\u2009\u00b1\u20093.7 weeks, the gestational age at termination was 36.3\u2009\u00b1\u20092.5 weeks and the mean gestational age of extension was 6.4\u2009\u00b1\u20094.2 weeks. Low molecular weight heparin sodium was administered after umbilical artery embolism was detected on ultrasound. The LWMHs treatment received by the included patients in this study was subcutaneous injection. The specific usage varies due to the types of LWMHs. Of the 10 cases, 5 (50%) had fetal distress but all fetuses were born alive without neonatal asphyxia. With regards to delivery mode, 9 pregnancies were terminated by cesarean section.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lesson:<\/jats:title>\n            <jats:p>Early anticoagulant treatment with LWMHs may improve pregnancy outcomes. The timing and mode of termination of pregnancy should be determined according to the condition of the mother and the fetus along with the gestational age.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000033501","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T14:05:42Z","timestamp":1681481142000},"page":"e33501","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["Application of low molecular weight heparins in umbilical artery thrombosis: A case series and review of the literature"],"prefix":"10.1097","volume":"102","author":[{"given":"Ting","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Women\u2019s Hospital Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingsha","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Women\u2019s Hospital Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Women\u2019s Hospital Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenshan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Women\u2019s Hospital Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Ultrasonography, Women\u2019s Hospital Zhejiang University School of Medicine, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"He","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Women\u2019s Hospital Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Women\u2019s Hospital Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"10524","DOI":"10.3390\/ijms221910524","article-title":"Heparin and its derivatives: challenges and advances in therapeutic biomolecules.","volume":"22","author":"Banik","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.biochi.2020.04.015","article-title":"Murine cellular model of mucopolysaccharidosis, type IIIB (MPS IIIB) - a preliminary study with particular emphasis on the non-oxidative l-cysteine metabolism.","volume":"174","author":"Kaczor-Kami\u0144ska","year":"2020","journal-title":"Biochimie"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1160\/TH08-01-0032","article-title":"Heparin and low-molecular-weight heparin.","volume":"99","author":"Gray","year":"2008","journal-title":"Thromb Haemost"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/bs.pmbts.2019.02.003","article-title":"Low molecular weight heparins and their clinical applications.","volume":"163","author":"Hao","year":"2019","journal-title":"Prog Mol Biol Transl Sci"},{"key":"R5-20250504","first-page":"6324362","article-title":"Umbilical artery thrombosis with associated acute and severe fetal growth restriction and transient severe protein s deficiency: report of a case with prenatal ultrasound diagnosis allowing for timely intervention and good outcome.","volume":"2018","author":"Alhousseini","year":"2018","journal-title":"Case Rep Obstet Gynecol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000449275","article-title":"Small at birth, but how small? The definition of SGA revisited.","volume":"86","author":"Zeve","year":"2016","journal-title":"Horm Res Paediatr"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/jmf.17.2.93.100","article-title":"The umbilical coiling index, a review of the literature.","volume":"17","author":"de Laat","year":"2005","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0002-9378(15)33305-6","article-title":"The nonstress test: how long is enough?","volume":"141","author":"Brown","year":"1981","journal-title":"Am J Obstet Gynecol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0002-9378(80)90568-2","article-title":"Antepartum fetal heart rate testing. IV. The nonstress test as a primary approach.","volume":"136","author":"Keegan","year":"1980","journal-title":"Am J Obstet Gynecol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0002-9378(80)90569-4","article-title":"Antepartum fetal heart rate testing. V. The nonstress test--an outpatient approach.","volume":"136","author":"Keegan","year":"1980","journal-title":"Am J Obstet Gynecol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0140-6736(72)91595-4","article-title":"Efficacy of low doses of heparin in prevention of deep-vein thrombosis after major surgery. A double-blind, randomised trial.","volume":"2","author":"Kakkar","year":"1972","journal-title":"Lancet"},{"issue":"Suppl 3","key":"R13-20250504","first-page":"5","article-title":"Production and chemical processing of low molecular weight heparins.","volume":"25","author":"Linhardt","year":"1999","journal-title":"Semin Thromb Hemost"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2141.1995.tb03373.x","article-title":"Low molecular weight heparin(s).","volume":"90","author":"Barrowcliffe","year":"1995","journal-title":"Br J Haematol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1062-0303(97)90057-1","article-title":"Low-molecular-weight heparin.","volume":"15","author":"Nunnelee","year":"1997","journal-title":"J Vasc Nurs"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.beha.2004.03.001","article-title":"Low- and ultra-low-molecular-weight heparins.","volume":"17","author":"Kakkar","year":"2004","journal-title":"Best Pract Res Clin Haematol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/GCO.0b013e328317a427","article-title":"Thromboembolism in pregnancy: recurrence risks, prevention and management.","volume":"20","author":"James","year":"2008","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/01.AOG.0000172428.78411.b0","article-title":"Incidence and risk factors for stroke in pregnancy and the puerperium.","volume":"106","author":"James","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1161\/CIRCULATIONAHA.105.576751","article-title":"Acute myocardial infarction in pregnancy: a United States population-based study.","volume":"113","author":"James","year":"2006","journal-title":"Circulation"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-143-10-200511150-00006","article-title":"Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study.","volume":"143","author":"Heit","year":"2005","journal-title":"Ann Intern Med"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2005-02-0626","article-title":"Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy.","volume":"106","author":"Greer","year":"2005","journal-title":"Blood"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1055\/s-0041-1726374","article-title":"Anti-Xa monitoring of low-molecular-weight heparin during pregnancy: a systematic review.","volume":"47","author":"Kjaergaard","year":"2021","journal-title":"Semin Thromb Hemost"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/OGX.0000000000000505","article-title":"The safety of low-molecular-weight heparin during and after pregnancy.","volume":"72","author":"Lu","year":"2017","journal-title":"Obstet Gynecol Surv"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/MBC.0b013e3283299c02","article-title":"Efficacy and safety of the long-term administration of low-molecular-weight heparins in pregnancy.","volume":"20","author":"Santoro","year":"2009","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2350\/13-11-1407-OA.1","article-title":"Umbilical artery thrombosis is a rare but clinically important finding: a series of 7 cases with clinical outcomes.","volume":"17","author":"Shilling","year":"2014","journal-title":"Pediatr Dev Pathol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/15513818809022278","article-title":"Thrombosis of the umbilical cord: analysis of 52 cases and literature review.","volume":"8","author":"Heifetz","year":"1988","journal-title":"Pediatr Pathol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0046-8177(95)90118-3","article-title":"Fetal thrombotic vasculopathy: the clinical significance of extensive avascular villi.","volume":"26","author":"Redline","year":"1995","journal-title":"Hum Pathol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033501","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:41:03Z","timestamp":1746326463000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,14]]},"references-count":26,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000033501","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,14]]}}}